Skip to main content

Table 1 Patient characteristics

From: Predictive value of cardiac magnetic resonance right ventricular longitudinal strain in patients with suspected myocarditis

 

Overall

RV GLS abnormal

RV GLS normal

p value

  

(> − 15.4%)

(≤ − 15.4%)

 

N = 659

N = 144

N = 515

Demographical data

    

 Gender (male) n (%)

414 (62.8)

102 (70.8)

312 (60.6)

0.024

 Age [years] mean ± SD

48.1 ± 16.1

49.5 ± 15.4

47.7 ± 16.3

0.240

 BMI [kg/m2] mean ± SD

27.4 ± 5.9

28.4 ± 6.6

27.2 ± 5.7

0.024

 BSA [m2] mean ± SD

2.0 ± 0.3

2.0 ± 0.3

2.0 ± 0.3

0.319

Myocarditis symptoms n (%)

    

 Chest pain

248 (37.8)

25 (17.4)

223 (43.3)

< 0.001

 Arrhythmiaa

124 (18.8)

25 (17.4)

99 (19.2)

0.613

 Dyspnea NYHA II, III or IV

297 (45.1)

95 (67.4)

202 (39.2)

< 0.001

 Time symptom onset to CMR [days] median (IQR)c

10 (4–28)

14 (7–28)

8 (4–28)

0.038

Biomarkers

    

 Troponin T [ng/l] median (IQR)

19 (1–115)

5 (1–28)

29 (1–198)

< 0.001

 Above cutoffb n (% of availablec)

186 (55)

28 (37.8)

158 (59.8)

0.001

 Creatine kinase [U/l] median (IQR)

180 (80–505)

135 (56–416)

198 (89–523)

0.072

 Above cutoffb n (% of availablec)

159 (56.4)

27 (44.3)

132 (59.7)

0.031

ECG n (% of availablec)

    

 Left bundle branch block

55 (9.2)

22 (16.9)

33 (7.1)

0.001

 Right bundle branch block

37 (5.6)

7 (5.4)

30 (6.4)

0.673

 ST-segment elevation

57 (8.6)

6 (4.6)

51 (10.9)

0.029

  1. BMI: body-mass-index; BSA: body surface area; CMR: cardiovascular magnetic resonance; ECG: electrocardiogram; IQR: interquartile range; NYHA: New York Heart Association; RV GLS: right ventricular global longitudinal strain; SD: standard deviation
  2. aArrhythmia comprised ECG-documented sustained and non-sustained ventricular tachycardia
  3. bCutoff values for elevated troponin T and creatine kinase were time- and site-specific according to the essay used for analysis, and > 190U/l, respectively
  4. cDate of symptom onset was available in 393 (59.6%) patients, troponin T was available in 338 (51.3%) patients, and creatine kinase in 282 (42.8%) patients. ECG was available in 598 (90.7%) patients